Literature DB >> 32808685

Acute arthritis following SARS-CoV-2 infection.

Vega Jovani1, Eliseo Pascual2, Paloma Vela1,2, Mariano Andrés1,2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32808685      PMCID: PMC7461394          DOI: 10.1002/jmv.26440

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   20.693


× No keyword cloud information.
Dear Editor, We have read with interest the article by Saricaoglu et al published in the recent issue of the Journal of Medical Virology. The authors diagnosed reactive arthritis in a 73‐year‐old male patient after the debut of polyarthritis in feet 8 days after finishing treatment for coronavirus disease‐2019 (COVID‐19). Although viral‐associated arthritis or reactive arthritis should be considered in differential diagnosis, they do not describe if the synovial fluid was analyzed. Some recent studies have described acute arthritis following severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection. , , Differential diagnosis should be made among viral arthritis, crystal‐associated arthritis, septic arthritis, or recent onset of any inflammatory rheumatic disease. Synovial fluid examination is essential to approach the diagnosis. Crystal‐associated arthritis, such as gout or pseudogout, is common in hospitalized patients for infections or other diseases. We described our experience of acute arthritis during COVID‐19 admission in four patients. A total of 306 patients with proven COVID‐19 were admitted to our hospital. Eighty‐one (26.4%) complained of muscle and joint pain at presentation. No patient had evident arthritis at admission, but four (1.3%) developed acute arthritis during hospitalization all due to crystal‐proven flares (gout and calcium pyrophosphate disease). Days from first COVID‐19 symptom to acute arthritis onset were, respectively, 8, 19, 8, and 27. The synovial fluid analysis allowed definitive diagnoses. Normal radiographies and normal uric acid do not exclude crystal‐associated arthritis since radiographies are normal in most gout patients and serum uric acid descends during the gout flares due to raised urate renal clearance. Sensitivity of the feet radiographies for CPP arthritis in the affected joints has not been evaluated. In the patient described by Saricaoglu et al, we noticed pathological nails that could correspond to psoriatic nails and if so, the arthritis could also be the onset of psoriatic arthritis. The diagnosis of reactive arthritis without a complete study and without a long follow‐up it is inaccurate. It is necessary to follow up patients with SARS‐CoV‐2 who developed new onset of arthritis but we want to insist that it remains essential to check the synovial fluid in every arthritis by polarized microscopy, especially in recent or acute arthritis—even during the SARS‐CoV‐2 pandemic.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.
  6 in total

1.  Serum uric acid in acute gout.

Authors:  J A Logan; E Morrison; P E McGill
Journal:  Ann Rheum Dis       Date:  1997-11       Impact factor: 19.103

2.  Hospitalization Increases the Risk of Acute Arthritic Flares in Gout: A Population-based Study over 2 Decades.

Authors:  Nour Zleik; Mohanad M Elfishawi; Zoran Kvrgic; Clement J Michet; Cynthia S Crowson; Eric L Matteson; Tim Bongartz
Journal:  J Rheumatol       Date:  2018-07-01       Impact factor: 4.666

3.  Case of acute arthritis following SARS-CoV-2 infection.

Authors:  Naoto Yokogawa; Naoto Minematsu; Harutaka Katano; Tadaki Suzuki
Journal:  Ann Rheum Dis       Date:  2020-06-26       Impact factor: 19.103

4.  Comparative analysis of synovial inflammation after SARS-CoV-2 infection.

Authors:  Stefano Alivernini; Antonella Cingolani; Marco Gessi; Annamaria Paglionico; Giuliana Pasciuto; Barbara Tolusso; Massimo Fantoni; Elisa Gremese
Journal:  Ann Rheum Dis       Date:  2020-07-06       Impact factor: 19.103

5.  Case series of acute arthritis during COVID-19 admission.

Authors:  María-Del-Carmen López-González; Maria Luisa Peral-Garrido; Irene Calabuig; Ernesto Tovar-Sugrañes; Vega Jovani; Pilar Bernabeu; Raquel García-Sevila; Jose-Manuel León-Ramírez; Oscar Moreno-Perez; Vicente Boix; Joan Gil; Esperanza Merino; Paloma Vela; Mariano Andrés
Journal:  Ann Rheum Dis       Date:  2020-05-29       Impact factor: 19.103

6.  The first reactive arthritis case associated with COVID-19.

Authors:  Elif M Saricaoglu; Imran Hasanoglu; Rahmet Guner
Journal:  J Med Virol       Date:  2020-07-19       Impact factor: 20.693

  6 in total
  3 in total

Review 1.  Decrypting the cellular and molecular intricacies associated with COVID-19-induced chronic pain.

Authors:  Mousmi Rani; Ankit Uniyal; Vinod Tiwari
Journal:  Metab Brain Dis       Date:  2022-07-18       Impact factor: 3.655

2.  Primary meningococcal arthritis in a COVID-19 18-year-old man: a case report and review of the literature.

Authors:  Norman Ducatez; Marine Chancel; Youcef Douadi; Charles Dayen; Rémi Suguenot; Emmanuelle Lecuyer; Benoit Brihaye; Houcine Bentayeb
Journal:  BMC Infect Dis       Date:  2021-05-29       Impact factor: 3.090

3.  A case of SARS-CoV-2-associated arthritis with detection of viral RNA in synovial fluid.

Authors:  Zachary Kuschner; Alexandra Ortega; Pinaki Mukherji
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.